News
Merck’s COVID-19 pill may be less effective than first hoped
November 30, 2021
The new results seem to put molnupiravir far below the effectiveness of existing treatments.
News
Scientists ask whether Omicron can outrun Delta: How fast does it spread?
November 29, 2021
The fact that Omicron is already spreading in the presence of Delta, “which outcompeted all the other variants, is worrisome.”
News
Intranasal vs. intramuscular naloxone in reversing opioid overdose
November 29, 2021
Is intranasal naloxone as effective as intramuscular naloxone in reversing opioid overdose at the same dose?
News
Comparing the efficacy and safety of common SIADH treatments
November 24, 2021
Is fluid restriction or the addition of furosemide with or without NaCl supplementation more efficacious for the treatment of hyponatremia caused by syndrome of inappropriate antidiuretic hormone (SIADH)?
News
Fueling an ‘already raging fire’: Fifth COVID surge approaches
November 24, 2021
“A significant rise in cases just before Thanksgiving is not what we want to be seeing.”
News
Acute urinary retention tied to increased risk of certain cancers
November 24, 2021
“Admission with a first-time acute urinary retention could be an opportunity to diagnose an occult cancer.”
News
Children and COVID: New cases increase for third straight week
November 23, 2021
Pace of vaccinations remains steady in 5- to 11-year-olds.
News
Short-acting opioids needed for withdrawal in U.S. hospitals, say experts
November 23, 2021
The short-acting drugs can complement methadone and buprenorphine to help patients get faster relief and help patients stay in the hospital to help with long-term management, say the authors of a new commentary.
News
‘Misleading’ results in colchicine COVID-19 trials meta-analysis
November 23, 2021
“While the small studies are potentially insight providing, the large studies are the only ones worth giving our attention to in the context of the meta-analysis.”
News
Breakthrough COVID-19 raises risk of health problems, death
November 23, 2021
Compared with people who never had COVID-19, those who had breakthrough infections had a 53% higher risk of death.